TALDO1
Transaldolase
Also known as: TALDO_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P37837
- Gene
- TALDO1
- Ensembl
- ENSG00000177156
- Chromosome
- 11
- Canonical length
- 337 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Transaldolase 1 is a key enzyme of the nonoxidative pentose phosphate pathway providing ribose-5-phosphate for nucleic acid synthesis and NADPH for lipid biosynthesis. This pathway can also maintain glutathione at a reduced state and thus protect sulfhydryl groups and cellular integrity from oxygen radicals. The functional gene of transaldolase 1 is located on chromosome 11 and a pseudogene is identified on chromosome 1 but there are conflicting map locations. The second and third exon of this gene were developed by insertion of a retrotransposable element. This gene is thought to be involved in multiple sclerosis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
337 residues, UniProt reviewed canonical sequence.
>P37837|TALDO1
1 MSSSPVKRQR MESALDQLKQ FTTVVADTGD FHAIDEYKPQ DATTNPSLIL AAAQMPAYQE
61 LVEEAIAYGR KLGGSQEDQI KNAIDKLFVL FGAEILKKIP GRVSTEVDAR LSFDKDAMVA
121 RARRLIELYK EAGISKDRIL IKLSSTWEGI QAGKELEEQH GIHCNMTLLF SFAQAVACAE
181 AGVTLISPFV GRILDWHVAN TDKKSYEPLE DPGVKSVTKI YNYYKKFSYK TIVMGASFRN
241 TGEIKALAGC DFLTISPKLL GELLQDNAKL VPVLSAKAAQ ASDLEKIHLD EKSFRWLHNE
301 DQMAVEKLSD GIRKFAADAV KLERMLTERM FNAENGKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TALDO1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 439 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 439 nTPM
- esophagus: 362 nTPM
- spinal cord: 194 nTPM
- spleen: 168 nTPM
- urinary bladder: 163 nTPM
- vagina: 153 nTPM
Single-cell type
- esophageal apical cells: 2,296 nCPM
- platelets: 1,606 nCPM
- neutrophils: 1,218 nCPM
- megakaryocytes: 1,014 nCPM
- esophageal suprabasal cells: 1,013 nCPM
- syncytiotrophoblasts: 676 nCPM
Immune cell
- neutrophil: 3,741 nTPM
- eosinophil: 2,877 nTPM
- basophil: 1,461 nTPM
- classical monocyte: 1,205 nTPM
- total PBMC: 1,065 nTPM
- myeloid DC: 655 nTPM
Brain region
- white matter: 154 nTPM
- medulla oblongata: 135 nTPM
- cerebellum: 118 nTPM
- basal ganglia: 114 nTPM
- spinal cord: 107 nTPM
- pons: 106 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TALDO1.
Disease | AllUniProt
Conditions TALDO1 is implicated in, by any mechanism.
- Transaldolase deficiency (TALDOD) MIM:606003
Disease | GeneticClinVar
27 pathogenic / likely-pathogenic of 310 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Deficiency of transaldolase
- TALDO1-related disorder
- Thyroid cancer, nonmedullary, 1
Disease | ImmuneIEDB
Conditions an epitope on TALDO1 was assayed in.
- multiple sclerosis B and T cell
ReferencesPubMed · IEDB
Publications for TALDO1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients.
1999 · J Immunol · RCR 0.7 · 32 citations - Evaluation of autoimmunity to transaldolase in multiple sclerosis.
2004 · Methods Mol Med · RCR 0 · 2 citations
Reference: B cellIEDB
1 publication
- High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
2016 · Mol Cell Proteomics · RCR 2.5 · 66 citations
Reference: T cellIEDB
1 publication
- CD8+ T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168-176 in patients with multiple sclerosis.
2005 · J Immunol · RCR 0.6 · 29 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.11
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.13
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carbohydrate metabolic process
- fructose 6-phosphate metabolic process
- pentose-phosphate shunt, non-oxidative branch
Molecular functions
- monosaccharide binding
- transaldolase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aldolase-type TIM barrel
- Transaldolase/Fructose-6-phosphate aldolase
- Transaldolase type 1
- Transaldolase, active site
- Transaldolase/Fructose-6-phosphate aldolase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TALDO1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TALDO1 as an antibody target. Whether an autoantibody or antibody against TALDO1 could matter depends on whether native TALDO1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TALDO1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TALDO1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...